SLT, Drops, or Surgery? How to Choose Your Next Step with Real Data
Hitting a pressure plateau can leave glaucoma patients wondering what to do next. Here's a side-by-side look at medications, selective laser trabeculoplasty, and MIGS options — and how home IOP data guides the decision.
Every glaucoma journey eventually reaches a crossroads: keep titrating drops, move to selective laser trabeculoplasty (SLT), or consider minimally invasive glaucoma surgery (MIGS). Without objective IOP data, it can feel like guesswork.
MyEyes patients use the iCare HOME2 to track how each therapy performs in daily life, not just on appointment days. Here's how to evaluate the big three options using your own pressure curves.
Option 1: Topical Drops
Best for: early to moderate disease, patients who tolerate drops well, and eyes that respond predictably.
- Pros: Non-invasive, inexpensive generics available, easy to adjust.
- Cons: Adherence challenges, systemic side effects, pressure drift between doses.
- How HOME2 helps: Tag readings ‘pre-drop’ and ‘post-drop’ to quantify the actual mmHg reduction and duration of effect.
Option 2: Selective Laser Trabeculoplasty
Best for: patients tired of multi-drop regimens, early surgical candidates, and eyes with open angles.
- Pros: Can replace or reduce drops for several years, office-based, repeatable.
- Cons: Effect can fade, not ideal for narrow angles or advanced scarring.
- How HOME2 helps: Capture baseline pressures for 1-2 weeks, then resume measurements 48 hours post-SLT to document the new curve. Send your surgeon a chart instead of anecdotes.
Option 3: MIGS or Filtering Surgery
Best for: patients with documented progression, high risk on PRS, or those already on maximal drops.
- Pros: Larger, longer-lasting pressure reductions, can be combined with cataract surgery.
- Cons: Higher upfront risk, recovery time, insurance pre-approvals.
- How HOME2 helps: Track pressures hourly during recovery without extra office visits. Flag rebound spikes early so your surgeon can intervene.
Use Data to Personalize the Timeline
Bring a 30-day HOME2 graph to your next appointment. Highlight:
- Median pressure vs. your doctor’s target
- Frequency of spikes >3 mmHg over target
- Night vs. day variance to show whether SLT or MIGS is necessary
Doctors make surgical recommendations faster when they can see hard data instead of hearing ‘my eyes feel weird at night.’
Financing Considerations
SLT is often covered as an in-office procedure. MIGS is bundled with cataract surgery or billed separately. If you need bridge time to gather more data, the HOME2 rental lets you keep monitoring while insurance approvals process.
Key Takeaway
Use your home IOP dataset to have a collaborative conversation. Instead of ‘I think my drops aren’t working,’ you can say ‘My median pressure is 19 mmHg with nightly spikes to 26 despite full adherence.’ That sentence gets attention.
Ready to Start Monitoring?
Rent or purchase a HOME2 tonometer with support from our Patient Ambassadors.
Get Started